Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122636823 | 12263682 | 3 | F | 20160403 | 20160913 | 20160413 | 20160920 | EXP | PHHY2015BR111301 | NOVARTIS | 60.95 | YR | M | Y | 85.00000 | KG | 20160920 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122636823 | 12263682 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO, (ONCE A MONTH) | U | 21008 | 20 | MG | VIAL | /month | |||||
122636823 | 12263682 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | U | 21008 | VIAL | ||||||||||
122636823 | 12263682 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | U | 21008 | VIAL | ||||||||||
122636823 | 12263682 | 4 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Unknown | UNK | U | 0 | |||||||||
122636823 | 12263682 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 3 DF, QD | 0 | 3 | DF | TABLET | QD | ||||||
122636823 | 12263682 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | UNK | 0 | ||||||||||
122636823 | 12263682 | 7 | C | VASTAREL | TRIMETAZIDINE DIHYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
122636823 | 12263682 | 8 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | 0 | ||||||||||
122636823 | 12263682 | 9 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | 3 DF, QD | 0 | 3 | DF | TABLET | QD | ||||||
122636823 | 12263682 | 10 | C | ASA | ASPIRIN | 1 | Unknown | UNK | 0 | ||||||||||
122636823 | 12263682 | 11 | C | TYLEX (PARACETAMOL) | 2 | Unknown | UNK | U | 0 | ||||||||||
122636823 | 12263682 | 12 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122636823 | 12263682 | 1 | Neuroendocrine tumour |
122636823 | 12263682 | 2 | Hepatic cancer |
122636823 | 12263682 | 3 | Gastrointestinal carcinoma |
122636823 | 12263682 | 4 | Product used for unknown indication |
122636823 | 12263682 | 5 | Diabetes mellitus |
122636823 | 12263682 | 6 | Myocardial infarction |
122636823 | 12263682 | 7 | Myocardial infarction |
122636823 | 12263682 | 8 | Myocardial infarction |
122636823 | 12263682 | 9 | Diabetes mellitus |
122636823 | 12263682 | 10 | Myocardial infarction |
122636823 | 12263682 | 11 | Product used for unknown indication |
122636823 | 12263682 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122636823 | 12263682 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122636823 | 12263682 | Abdominal distension | |
122636823 | 12263682 | Blood creatinine increased | |
122636823 | 12263682 | Blood pressure decreased | |
122636823 | 12263682 | Diabetes mellitus inadequate control | |
122636823 | 12263682 | Feeling abnormal | |
122636823 | 12263682 | Hypertension | |
122636823 | 12263682 | Malaise | |
122636823 | 12263682 | Muscle spasms | |
122636823 | 12263682 | Pain in extremity | |
122636823 | 12263682 | Renal disorder | |
122636823 | 12263682 | Venous occlusion | |
122636823 | 12263682 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122636823 | 12263682 | 1 | 2012 | 0 | ||
122636823 | 12263682 | 6 | 2009 | 0 | ||
122636823 | 12263682 | 7 | 2009 | 0 | ||
122636823 | 12263682 | 8 | 2009 | 0 | ||
122636823 | 12263682 | 10 | 2009 | 0 |